1-74216284-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001112808.3(FPGT-TNNI3K):​c.343+14874A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 151,502 control chromosomes in the GnomAD database, including 14,311 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 14311 hom., cov: 32)

Consequence

FPGT-TNNI3K
NM_001112808.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0520

Publications

12 publications found
Variant links:
Genes affected
FPGT-TNNI3K (HGNC:42952): (FPGT-TNNI3K readthrough) Enables protein C-terminus binding activity; protein kinase activity; and troponin I binding activity. Involved in protein phosphorylation and regulation of heart contraction. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
FPGT (HGNC:3825): (fucose-1-phosphate guanylyltransferase) L-fucose is a key sugar in glycoproteins and other complex carbohydrates since it may be involved in many of the functional roles of these macromolecules, such as in cell-cell recognition. The fucosyl donor for these fucosylated oligosaccharides is GDP-beta-L-fucose. There are two alternate pathways for the biosynthesis of GDP-fucose; the major pathway converts GDP-alpha-D-mannose to GDP-beta-L-fucose. The protein encoded by this gene participates in an alternate pathway that is present in certain mammalian tissues, such as liver and kidney, and appears to function as a salvage pathway to reutilize L-fucose arising from the turnover of glycoproteins and glycolipids. This pathway involves the phosphorylation of L-fucose to form beta-L-fucose-1-phosphate, and then condensation of the beta-L-fucose-1-phosphate with GTP by fucose-1-phosphate guanylyltransferase to form GDP-beta-L-fucose. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream TNNI3 interacting kinase (TNNI3K) gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001112808.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FPGT-TNNI3K
NM_001112808.3
c.343+14874A>G
intron
N/ANP_001106279.3
FPGT-TNNI3K
NM_001199327.2
c.343+14874A>G
intron
N/ANP_001186256.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FPGT-TNNI3K
ENST00000557284.7
TSL:2
c.343+14874A>G
intron
N/AENSP00000450895.3
FPGT-TNNI3K
ENST00000370899.7
TSL:2
c.343+14874A>G
intron
N/AENSP00000359936.3
FPGT-TNNI3K
ENST00000370895.5
TSL:2
c.343+14874A>G
intron
N/AENSP00000359932.1

Frequencies

GnomAD3 genomes
AF:
0.413
AC:
62525
AN:
151384
Hom.:
14318
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.212
Gnomad AMI
AF:
0.626
Gnomad AMR
AF:
0.424
Gnomad ASJ
AF:
0.563
Gnomad EAS
AF:
0.729
Gnomad SAS
AF:
0.546
Gnomad FIN
AF:
0.500
Gnomad MID
AF:
0.439
Gnomad NFE
AF:
0.476
Gnomad OTH
AF:
0.405
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.413
AC:
62521
AN:
151502
Hom.:
14311
Cov.:
32
AF XY:
0.418
AC XY:
30946
AN XY:
74044
show subpopulations
African (AFR)
AF:
0.212
AC:
8767
AN:
41386
American (AMR)
AF:
0.424
AC:
6425
AN:
15158
Ashkenazi Jewish (ASJ)
AF:
0.563
AC:
1946
AN:
3458
East Asian (EAS)
AF:
0.729
AC:
3732
AN:
5122
South Asian (SAS)
AF:
0.544
AC:
2620
AN:
4814
European-Finnish (FIN)
AF:
0.500
AC:
5271
AN:
10550
Middle Eastern (MID)
AF:
0.442
AC:
129
AN:
292
European-Non Finnish (NFE)
AF:
0.476
AC:
32205
AN:
67708
Other (OTH)
AF:
0.407
AC:
855
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1752
3504
5256
7008
8760
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.420
Hom.:
2278
Bravo
AF:
0.400
Asia WGS
AF:
0.543
AC:
1891
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.94
DANN
Benign
0.44
PhyloP100
-0.052
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs792321; hg19: chr1-74681968; COSMIC: COSV63846410; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.